Skip to main content
Fig. 3 | World Journal of Surgical Oncology

Fig. 3

From: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Fig. 3

Overall survival of 53 patients treated with CRS and HIPEC, grouped according to the organ of origin. Best survival is observed in pseudomyxoma peritonei patients (n = 9), followed by ovarian (n = 15) and colorectal (n = 19) cancer patients. In this retrospective cohort, selected patients with gastric cancer (n = 6) and malignant mesothelioma (n = 4) have the worst prognosis

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us